Artiva Biotherapeutics (ARTV) Earnings Date, Estimates & Call Transcripts $2.08 +0.16 (+8.07%) Closing price 03:59 PM EasternExtended Trading$2.08 +0.00 (+0.24%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Artiva Biotherapeutics Earnings Summary Upcoming Q4 Earnings DateJun. 23Before Market OpensEstimatedConsensus EPS (Nov. 12) -$0.68 Actual EPS (Nov. 12) -$0.92 Missed By -$0.24 Artiva Biotherapeutics posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.92, which missed analysts' consensus estimates of -$0.68 by $0.24. With a trailing EPS of $0.00, Artiva Biotherapeutics' earnings are expected to grow next year, from ($4.95) to ($2.83) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings Report Quarterly Report (10-Q) Press Release (8-K)ARTV Upcoming EarningsArtiva Biotherapeutics' next earnings date is estimated for Monday, June 23, 2025, based on past reporting schedules. Powered by Get Artiva Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Artiva Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARTV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Artiva Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.62-$0.65Q2 20252-$0.70-$0.66-$0.68Q3 20252-$0.73-$0.70-$0.72Q4 20252-$0.77-$0.57-$0.67 Artiva Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/23/2025(Estimated)--------11/12/2024--$0.68-$0.92 -$0.24-$0.92$0.30M-8/29/2024Q2 2024-$1.07-$19.10 -$18.03-$16.20-- Artiva Biotherapeutics Earnings - Frequently Asked Questions When is Artiva Biotherapeutics's earnings date? Artiva Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 23rd, 2025 based off last year's report dates. Learn more on ARTV's earnings history. Did Artiva Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Artiva Biotherapeutics (NASDAQ:ARTV) missed the analysts' consensus estimate of ($0.68) by $0.24 with a reported earnings per share (EPS) of ($0.92). Learn more on analysts' earnings estimate vs. ARTV's actual earnings. How much revenue does Artiva Biotherapeutics generate each year? Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded annual revenue of $251,000.00. What is Artiva Biotherapeutics's EPS forecast for next year? Artiva Biotherapeutics's earnings are expected to grow from ($4.95) per share to ($2.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Corvus Pharmaceuticals Earnings Date Candel Therapeutics Earnings Date Design Therapeutics Earnings Date Cidara Therapeutics Earnings Date enGene Earnings Date Rezolute Earnings Date Bright Minds Biosciences Earnings Date Humacyte Earnings Date Protalix BioTherapeutics Earnings Date Kodiak Sciences Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Disney Stock Jumps on Earnings—Is the Magic Sustainable?Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release? This page (NASDAQ:ARTV) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe New ElonThe New Face of DOGE? There is now a new, powerful and controversial figure at the heart of the DOGE agenda...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Wealth is Being Erased – Save It Before It’s Gone ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
